Connect with us

Hi, what are you looking for?

Life

AI program aims to power-up medical research

The new platform comes from the medical artificial intelligence firm Fimmic. The technology group have launched a platform called aiForward. This is an open, global program designed for medical researchers and related fields, like pathology, who are willing to experiment with artificial intelligence in order to advance their research.

The aiForward program allows free of charge access for participants to a sophisticated artificial intelligence platform. To add to this, there is a support group of experts to assist. The focus is on the implementation of artificial intelligence in microscopic image analysis.

As Digital Journal has earlier reported, the digital transformation of pathology is gaining momentum worldwide. This has been noted across health and pharmaceutical sectors; together with education establishments and contract research organizations. For example, one report puts the worldwide market for digital pathology solutions at $5.7 billion.

The new artificial intelligence platform is part of this expanding field. The aiForward program allows researchers to develop a purpose-built image analysis algorithm designed for specific research interests.

According to Kaisa Helminen, who is the CEO of Fimmic, in a statement sent to Digital Journal: “The aiForward program is all about putting AI into the hands of medical researchers and pathologists. It is about moving AI forward, from vision to practice, and facilitating new discoveries in medical sciences.”

This extends to research projects focused on microscopic analysis of pathological or histological sample images. Such investigations assist medical areas like cancer, neurology, infectious diseases or lifestyle diseases. The artificial intelligence will assist with the automation of tasks and allow for image data to be sorted and reviewed relatively speedily.

To participate, researchers need to apply and their applications will be reviewed by an independent Advisory Team. Those selected will be granted free of charge access to Fimmic’s cloud-based, self-service AI tool, Aiforia® Create, to allow the researchers to progress the development of purpose-built algorithms. Aiforia Cloud is already used by more than 6,000 pathologists, researchers and pharmaceutical R&D teams to manage and share digital slide collections.

The program will also enable a community of researchers to be created where ideas and research can be shared.

Written By

Dr. Tim Sandle is Digital Journal's Editor-at-Large for science news. Tim specializes in science, technology, environmental, and health journalism. He is additionally a practising microbiologist; and an author. He is also interested in history, politics and current affairs.

You may also like:

World

With fish and turtles swimming around them, divers performed an underwater lion dance on the traditional Lunar New Year.

World

The "Doomsday Clock," representing the judgment of leading science and security experts about perils to human existence.

World

Russian President Vladimir Putin looks on during a meeting with Iranian President in Moscow on January 19, 2022. - Copyright SPUTNIK/AFP Pavel BEDNYAKOVAndrew BEATTY,...

Sports

The app also grants permission to hear audio, allowing bad actors the possibility of engaging with the audio or listening to an athlete.